Solventum Corporation (NYSE:SOLV) Receives $84.89 Consensus Target Price from Brokerages

by · The Cerbat Gem

Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have received an average recommendation of “Hold” from the twelve analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $85.5556.

Several equities analysts have weighed in on the stock. Jefferies Financial Group initiated coverage on shares of Solventum in a report on Thursday, September 11th. They set a “hold” rating and a $80.00 price target on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Solventum in a research note on Thursday, October 30th. UBS Group upped their target price on shares of Solventum from $77.00 to $79.00 and gave the stock a “neutral” rating in a report on Monday. Wells Fargo & Company increased their price target on Solventum from $79.00 to $82.00 and gave the stock an “equal weight” rating in a research note on Monday, September 15th. Finally, Piper Sandler boosted their price objective on Solventum from $94.00 to $98.00 and gave the company an “overweight” rating in a research report on Friday.

Read Our Latest Stock Report on SOLV

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SOLV. Strengthening Families & Communities LLC grew its holdings in Solventum by 376.8% during the 1st quarter. Strengthening Families & Communities LLC now owns 329 shares of the company’s stock valued at $25,000 after buying an additional 260 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in Solventum during the second quarter valued at $28,000. Deseret Mutual Benefit Administrators grew its stake in Solventum by 78.7% during the third quarter. Deseret Mutual Benefit Administrators now owns 370 shares of the company’s stock valued at $27,000 after acquiring an additional 163 shares in the last quarter. Barrett & Company Inc. increased its holdings in Solventum by 206.2% in the 2nd quarter. Barrett & Company Inc. now owns 398 shares of the company’s stock valued at $30,000 after acquiring an additional 268 shares during the last quarter. Finally, MUFG Securities EMEA plc purchased a new stake in Solventum in the 2nd quarter worth $31,000.

Solventum Stock Performance

Shares of SOLV opened at $71.83 on Thursday. The business has a 50-day simple moving average of $71.94 and a two-hundred day simple moving average of $72.51. The company has a quick ratio of 1.14, a current ratio of 1.50 and a debt-to-equity ratio of 1.03. Solventum has a 52 week low of $60.70 and a 52 week high of $85.92. The stock has a market cap of $12.46 billion, a price-to-earnings ratio of 8.28, a PEG ratio of 2.88 and a beta of 0.49.

Solventum (NYSE:SOLV – Get Free Report) last posted its quarterly earnings data on Thursday, November 6th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.43 by $0.07. The firm had revenue of $2.10 billion for the quarter, compared to analysts’ expectations of $2.05 billion. Solventum had a return on equity of 28.01% and a net margin of 18.13%.The business’s quarterly revenue was up .7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.64 EPS. Solventum has set its FY 2025 guidance at 5.980-6.080 EPS. On average, analysts expect that Solventum will post 6.58 EPS for the current year.

About Solventum

(Get Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Featured Articles